Abstract
Many solid tumors, including non-small cell lung cancers (NSCLCs), are characterized by heterogenous expression of p53 protein in the neoplastic cells. To analyse the molecular implications of this finding, we examined topographic distribution of p53 mutations using in situ polymerase chain reaction (PCR) in primary NSCLCs, showing distinct patterns of variable p53 overexpression by immunohistochemistry. Unique sets of primers for each mutation were designed, and optimal PCR conditions were determined by standard PCR using DNA from cloned mutants or cell lines established from these tumors. All tumor cell nuclei, regardless of the status of p53 overexpression, demonstrated homogeneous distribution of mutant p53 with specific primers, indicating that only subgroups of the mutated cells overexpressed p53 protein. In situ reverse transcription (RT)–PCR was applied to detect mutant mRNA in the individual tumor cells using specific primers. We found that in each case the distribution of mutant p53 mRNA coincided with that of immunohistochemical overexpression of p53 protein. Our results suggest that the regulation of mutant p53 expression, but not the genotype, is heterogeneous in the neoplastic cells. The topographic genomapping of p53 in NSCLC using in situ PCR provides a novel approach to view molecular mechanisms of lung carcinogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchagen DL, Nau MM, Gazdar AF, Linnoila RI . 1992 Oncogene 7: 743–749
Brambilla E, Gazzeri S, Moro D, Fromentel C, Gouyer V, Jacrot M, Brambilla C . 1993 Am. J. Pathol. 143: 199–210
Cha RS, Zarbl H, Keohavong P, Thilly WG . 1992 PCR Meth. Appl. 2: 14–20
Ebina M, Steinberg SM, Mulshine JM, Linnoila RI . 1994 Cancer Res. 54: 2496–2503
Greenblatt MS, Bennett WP, Hollstein M, Harris CC . 1994 Cancer Res. 54: 4855–4878
Hall KL, Teneriello MG, Taylor RR, Lemon S, Ebina M, Linnoila RI, Norris JH, Park RC, Birrer MJ . 1997 Gynecol. Oncol. 65: 330–335
Hasse AT, Retzel EF, Staskus KA . 1990 Proc. Natl. Acad. Sci. USA 87: 4971–4975
Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R, Takahashi T . 1993 Cancer Res. 53: 1–4
Kanazawa H, Ebina M, Ino-Oka N, Shimizukawa M, Takahashi T, Fujimura S, Imai T, Nukiwa T . 2000 Am. J. Pathol. 156: 1289–1298
Kirch H-C, Flaswinkel S, Rumpf H, Brockmann D, Esche H . 1999 Oncogene 18: 2728–2738
Martínez A, Miller MJ, Quinn K, Unsworth EJ, Ebina M, Cuttita F . 1995 J. Histochem. Cytochem. 43: 739–747
Mitsudomi T, Steinberg SM, Nau M M, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD, Gazdar AF . 1992 Oncogene 7: 171–180
Nuovo GJ . 1994 Protocols and Applications. 2nd ed. Nuovo GJ. (ed.) Raven Press: New York pp. 169–213
Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG . 1999 Proc. Natl. Acad. Sci. USA 96: 12754–12759
Oren M, Maltzman W, Levine AJ . 1981 Mol. Cell Biol. 1: 101–110
Park IW, Wistuba II, Maitra A, Milchgrub S, Virmani AK, Minna JD, Gazdar AF . 1999 J. Natl. Cancer Inst. 91: 1863–1868
Prives C . 1998 Cell 95: 5–8
Reihsaus E, Kohler M, Kraiss S, Oren M, Montenarh M . 1990 Oncogene 5: 137–145
Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF . 1999 Genes Dev. 13: 607–619
Shaw GL, Gazdar AF, Phelps R, Steinberg SM, Linnoila RI, Johnson BE, Oie HK, Russell EK, Ghosh BC, Pass HI, Minna JD, Mulshine JL, Ihde DC . 1996 J. Cell Biochem. 24: 173–185
Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD . 1989 Science 246: 491–494
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ebina, M., Martínez, A., Birrer, M. et al. In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancers. Oncogene 20, 2579–2586 (2001). https://doi.org/10.1038/sj.onc.1204351
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204351